Related Experiment Video
Updated: May 3, 2026
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Vaccine therapy for pancreatic cancer
Bulent Salman1, Donger Zhou2, Elizabeth M Jaffee3
1Department of Surgery; Johns Hopkins University of School of Medicine; Baltimore, MD USA ; The Sol Goldman Pancreatic Cancer Research Center; Johns Hopkins University School of Medicine; Baltimore, MD USA ; The Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University School of Medicine; Baltimore, MD USA.
Abstract:
Pancreatic cancer is a lethal disease and currently available therapies have significant limitations. Pancreatic cancer is thus an ideal setting for the development of novel treatment modalities such as immunotherapy. However, relevant obstacles must be overcome for immunotherapeutic regimens against pancreatic cancer to be successful. Vaccine therapy relies on the administration of biological preparations that include an antigen that (at least ideally) is specifically expressed by malignant cells, boosting the natural ability of the immune system to react against neoplastic cells. There are a number of ways to deliver anticancer vaccines. Potent vaccines stimulate antigen presentation by dendritic cells, hence driving the expansion of antigen-specific effector and memory T cells. Unlike vaccines given as a prophylaxis against infectious diseases, anticancer vaccines require the concurrent administration of agents that interfere with the natural predisposition of tumors to drive immunosuppression. The safety and efficacy of vaccines against pancreatic cancer are nowadays being tested in early phase clinical trials.
Insights
Pancreatic cancer immunotherapy, particularly vaccine therapy, shows promise but faces challenges. Novel approaches are being tested in clinical trials to overcome tumor-induced immunosuppression and improve treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Pancreatic cancer is a deadly disease with limited treatment options.
- Immunotherapy, especially vaccine therapy, presents a promising avenue for novel pancreatic cancer treatments.
- Significant obstacles hinder the success of current immunotherapeutic strategies.
Approach:
- Vaccine therapy involves administering biological preparations with tumor-specific antigens to stimulate the immune system.
- Effective vaccines promote antigen presentation by dendritic cells, leading to T cell expansion.
- Anticancer vaccines necessitate co-administration of agents to counteract tumor-induced immunosuppression.
Key Points:
- Pancreatic cancer necessitates innovative treatment modalities beyond conventional therapies.
- Vaccine therapy aims to harness the immune system against cancer cells by targeting specific antigens.
- Overcoming the tumor's immunosuppressive microenvironment is crucial for effective anticancer vaccines.
Conclusions:
- Early-phase clinical trials are evaluating the safety and efficacy of pancreatic cancer vaccines.
- Developing successful pancreatic cancer immunotherapies requires addressing inherent tumor-related challenges.
- Future research focuses on enhancing immune responses and overcoming immunosuppression for pancreatic cancer treatment.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers